1315 Capital

1315 Capital company information, Employees & Contact Information

Explore related pages

Related company profiles:

1315 Capital provides expansion and growth capital to commercial-stage healthcare services, medical technology, medtech & pharma outsourcing, and health & wellness companies. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$40 million investments in commercial healthcare entities that we believe have the potential to scale to approximately $100 million of revenue, a level we believe is highly attractive for acquisition or to access the public markets. In addition to experienced investing partners, 1315 Capital leverages an operating partner model of CEO and “Right Hand” COO Executive, a partnership that works together to navigate diligence, drive decisions, and seeks to achieve premium exits. Three operating teams contribute their collective experience to 1315 Capital in the areas of medical technologies, healthcare services, and specialty therapeutics. These three teams have built companies from expansion and growth phases to entities with revenues in excess of $100 million, resulting in almost $5 billion of aggregate exit value.

Company Details

Employees
25
Founded
-
Address
2929 Walnut Street, Suite 1240, Philadelphia,pa 19104,united States
Phone
215-662-1315
Email
te****@****tal.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Philadelphia, PA
Looking for a particular 1315 Capital employee's phone or email?

1315 Capital Questions

News

USpharma Ltd. Secures Growth Capital Investment by 1315 Capital - citybiz

USpharma Ltd. Secures Growth Capital Investment by 1315 Capital citybiz

Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital - PR Newswire

Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital PR Newswire

Experic Announces Growth Capital Investment Led by 1315 Capital - Business Wire

Experic Announces Growth Capital Investment Led by 1315 Capital Business Wire

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics - PR Newswire

Primrose Bio Announces Investment from 1315 Capital to Advance Manufacturing Solutions for Next-Generation Therapeutics PR Newswire

Triple Ring Technologies and 1315 Capital Announce Strategic Growth Partnership - PR Newswire

Triple Ring Technologies and 1315 Capital Announce Strategic Growth Partnership PR Newswire

1315 Capital Acquires Majority Stake in Leading Employer Focused Healthcare Cost Containment Company - PR Newswire

1315 Capital Acquires Majority Stake in Leading Employer Focused Healthcare Cost Containment Company PR Newswire

Biocoat, Inc. Announces Strategic Investment by GTCR - PR Newswire

Biocoat, Inc. Announces Strategic Investment by GTCR PR Newswire

Colorescience® Announces Successful Completion of $15 Million Series C Preferred Stock Financing - PR Newswire

Colorescience® Announces Successful Completion of $15 Million Series C Preferred Stock Financing PR Newswire

Top 1315 Capital Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant